Press "Enter" to skip to content

Aurobindo acquires 7 oncology drugs from spectrum for $300 million

Nasdaq-listed Spectrum Pharmaceuticals has carved out its commercial business inclusive of seven marketed oncology injectable products, intellectual property and commercial infrastructure.

Original source: https://health.economictimes.indiatimes.com/news/pharma/aurobindo-acquires-7-oncology-drugs-from-spectrum-for-300-million/67581420?utm_source=RSS&utm_medium=ETRSS

Also Read:   Aurobindo Pharma gets USFDA nod for generic Droxidopa capsules